🇺🇸 FDA
Patent

US 11787833

Modified cyclic dinucleoside compounds as sting modulators

granted A61KA61K9/0019A61P

Quick answer

US patent 11787833 (Modified cyclic dinucleoside compounds as sting modulators) held by Aligos Therapeutics, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K9/0019, A61P, A61P35/00, A61P35/04